pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,,
Regulation of RhoA activity,PID,3,MYO9B_HUMAN;RHG06_HUMAN;GDIR2_HUMAN,46 (48),0.00202,1,0.000531915,94
Protein processing in endoplasmic reticulum - Homo sapiens (human),KEGG,5,MBTP1_HUMAN;NGLY1_HUMAN;LMA1L_HUMAN;UBQL4_HUMAN;BAP31_HUMAN,165 (165),0.00208,1,,
Carbamazepine Pathway_ Pharmacokinetics,PharmGKB,2,CP1A2_HUMAN;MRP2_HUMAN,16 (16),0.00338,1,,
Formation of RNA Pol II elongation complex ,Reactome,3,CCNT2_HUMAN;AF9_HUMAN;SSRP1_HUMAN,64 (65),0.00518,1,,
RNA Polymerase II Transcription Elongation,Reactome,3,CCNT2_HUMAN;AF9_HUMAN;SSRP1_HUMAN,64 (65),0.00518,1,,
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Reactome,1,CP1A2_HUMAN,1 (1),0.00548,1,,
O-linked glycosylation of mucins,Reactome,3,MUC5A_HUMAN;GLTL6_HUMAN;GCNT7_HUMAN,67 (67),0.00588,1,,
Rho GTPase cycle,Reactome,4,ARHGJ_HUMAN;MYO9B_HUMAN;RHG06_HUMAN;GDIR2_HUMAN,140 (144),0.00725,1,,
Pathway_PA165986194 -need delete,PharmGKB,2,CP1A2_HUMAN;MRP5_HUMAN,24 (24),0.00756,1,,
Acetaminophen Pathway_ Pharmacokinetics,PharmGKB,2,CP1A2_HUMAN;MRP5_HUMAN,24 (24),0.00756,1,,
nfkb activation by nontypeable hemophilus influenzae,BioCarta,2,MUC5A_HUMAN;MP2K3_HUMAN,29 (29),0.0109,1,,
Hyaluronan biosynthesis and export,Reactome,1,MRP5_HUMAN,2 (2),0.0109,1,,
Lidocaine metabolism,Wikipathways,1,CP1A2_HUMAN,2 (2),0.0109,1,,
mucin core 1 and core 2 <i>O</i>-glycosylation,HumanCyc,2,GLTL6_HUMAN;GCNT7_HUMAN,30 (30),0.0117,1,,
RNA Polymerase II Pre-transcription Events,Reactome,3,CCNT2_HUMAN;AF9_HUMAN;SSRP1_HUMAN,87 (88),0.012,1,,
Galactose metabolism - Homo sapiens (human),KEGG,2,UGPA_HUMAN;MGAL_HUMAN,31 (31),0.0124,1,,
Acetaminophen Metabolism Pathway,SMPDB,2,CP1A2_HUMAN;MRP5_HUMAN,31 (31),0.0124,1,,
Sialic acid metabolism,Reactome,2,SIA7E_HUMAN;SIA10_HUMAN,33 (33),0.014,1,,
Nuclear Receptors in Lipid Metabolism and Toxicity,Wikipathways,2,CP1A2_HUMAN;MRP2_HUMAN,33 (35),0.014,1,,
Fluoropyrimidine Activity,Wikipathways,2,MRP5_HUMAN;SMUG1_HUMAN,33 (34),0.014,1,,
Formation of the active cofactor_ UDP-glucuronate,Reactome,1,UGPA_HUMAN,3 (3),0.0164,1,,
Starch and sucrose metabolism - Homo sapiens (human),KEGG,2,UGPA_HUMAN;MGAL_HUMAN,36 (36),0.0166,1,,
DNA Damage Recognition in GG-NER,Reactome,2,CSN6_HUMAN;ARP8_HUMAN,38 (38),0.0183,1,,
Liver steatosis AOP,Wikipathways,3,CP1A2_HUMAN;MRP2_HUMAN;LIPS_HUMAN,103 (103),0.0189,1,,
HIV elongation arrest and recovery,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,39 (40),0.0193,1,,
Pausing and recovery of HIV elongation,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,39 (40),0.0193,1,,
ATF6 (ATF6-alpha) activates chaperones,Reactome,1,MBTP1_HUMAN,4 (4),0.0218,1,,
Clomipramine Metabolism Pathway,SMPDB,1,CP1A2_HUMAN,4 (4),0.0218,1,,
Biosynthesis of protectins,Reactome,1,CP1A2_HUMAN,4 (4),0.0218,1,,
SLIT2:ROBO1 increases RHOA activity,Reactome,1,MYO9B_HUMAN,4 (4),0.0218,1,,
Imipramine/Desipramine Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,4 (4),0.0218,1,,
Theophylline Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,4 (4),0.0218,1,,
Clomipramine Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,4 (4),0.0218,1,,
Lidocaine (Local Anaesthetic) Metabolism Pathway,SMPDB,1,CP1A2_HUMAN,4 (4),0.0218,1,,
Caffeine and Theobromine metabolism,Wikipathways,1,CP1A2_HUMAN,4 (4),0.0218,1,,
ABC transporters - Homo sapiens (human),KEGG,2,MRP5_HUMAN;MRP2_HUMAN,44 (44),0.0242,1,,
O-linked glycosylation,Reactome,3,MUC5A_HUMAN;GLTL6_HUMAN;GCNT7_HUMAN,116 (116),0.0257,1,,
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,Reactome,1,LRRF1_HUMAN,5 (5),0.0271,1,,
Caffeine metabolism - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,5 (5),0.0271,1,,
Reelin signalling pathway,Reactome,1,VLDLR_HUMAN,5 (5),0.0271,1,,
Sulindac Metabolic Pathway,Wikipathways,1,CP1A2_HUMAN,5 (5),0.0271,1,,
Sperm:Oocyte Membrane Binding,Reactome,1,IZUM1_HUMAN,5 (5),0.0271,1,,
Doxepin Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,5 (5),0.0271,1,,
Doxepin Metabolism Pathway,SMPDB,1,CP1A2_HUMAN,5 (5),0.0271,1,,
Glycosaminoglycan metabolism,Reactome,3,MRP5_HUMAN;SIA10_HUMAN;HS3S6_HUMAN,119 (119),0.0275,1,,
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,2,UGPA_HUMAN;CHIT1_HUMAN,48 (48),0.0284,1,,
miR-targeted genes in squamous cell - TarBase,Wikipathways,3,CTDS1_HUMAN;PICAL_HUMAN;UFO_HUMAN,122 (158),0.0293,1,,
Ciliary landscape,Wikipathways,4,PGRC2_HUMAN;CSN6_HUMAN;BBS1_HUMAN;RPGR_HUMAN,213 (213),0.0293,1,,
Formation of HIV elongation complex in the absence of HIV Tat,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,51 (52),0.0318,1,,
selenocysteine biosynthesis,HumanCyc,1,SPS1_HUMAN,6 (6),0.0325,1,,
VLDL clearance,Reactome,1,VLDLR_HUMAN,6 (6),0.0325,1,,
mechanism of acetaminophen activity and toxicity,BioCarta,1,CP1A2_HUMAN,6 (6),0.0325,1,,
d4gdi signaling pathway,BioCarta,1,GDIR2_HUMAN,6 (6),0.0325,1,,
mir-124 predicted interactions with cell cycle and differentiation,Wikipathways,1,CTDS1_HUMAN,6 (6),0.0325,1,,
Imipramine Metabolism Pathway,SMPDB,1,CP1A2_HUMAN,6 (6),0.0325,1,,
Lipid storage and perilipins in skeletal muscle,Wikipathways,1,LIPS_HUMAN,6 (6),0.0325,1,,
miR-targeted genes in muscle cell - TarBase,Wikipathways,5,VPS39_HUMAN;PDE3A_HUMAN;PICAL_HUMAN;UFO_HUMAN;SYNE1_HUMAN,329 (400),0.0342,1,,
Arylamine metabolism,Wikipathways,1,CP1A2_HUMAN,7 (7),0.0378,1,,
Docetaxel Action Pathway,SMPDB,1,MRP2_HUMAN,7 (7),0.0378,1,,
srebp control of lipid synthesis,BioCarta,1,MBTP1_HUMAN,7 (7),0.0378,1,,
Glycerophospholipid catabolism,Reactome,1,PLPL7_HUMAN,7 (7),0.0378,1,,
Tramadol Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,7 (7),0.0378,1,,
Paclitaxel Action Pathway,SMPDB,1,MRP2_HUMAN,7 (7),0.0378,1,,
Tramadol Metabolism Pathway,SMPDB,1,MRP2_HUMAN,7 (7),0.0378,1,,
Caffeine Metabolism,SMPDB,1,CP1A2_HUMAN,7 (7),0.0378,1,,
Caspase Cascade in Apoptosis,PID,2,SLK_HUMAN;GDIR2_HUMAN,57 (57),0.039,1,,
ABC-family proteins mediated transport,Reactome,2,MRP5_HUMAN;MRP2_HUMAN,59 (59),0.0415,1,,
rRNA modification in the nucleus and cytosol,Reactome,2,WDR43_HUMAN;DHX37_HUMAN,59 (59),0.0415,1,,
rRNA processing in the nucleus and cytosol,Reactome,2,WDR43_HUMAN;DHX37_HUMAN,59 (59),0.0415,1,,
Aflatoxin B1 metabolism,Wikipathways,1,CP1A2_HUMAN,8 (8),0.043,1,,
glycogen biosynthesis,HumanCyc,1,UGPA_HUMAN,8 (8),0.043,1,,
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Reactome,1,CP1A2_HUMAN,8 (8),0.043,1,,
CREB3 factors activate genes,Reactome,1,MBTP1_HUMAN,8 (8),0.043,1,,
Biosynthesis of maresin-like SPMs,Reactome,1,CP1A2_HUMAN,8 (8),0.043,1,,
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,Reactome,1,SMUG1_HUMAN,8 (8),0.043,1,,
Cleavage of the damaged pyrimidine ,Reactome,1,SMUG1_HUMAN,8 (8),0.043,1,,
Depyrimidination,Reactome,1,SMUG1_HUMAN,8 (8),0.043,1,,
Terminal pathway of complement,Reactome,1,CO8A_HUMAN,8 (8),0.043,1,,
Warfarin Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,8 (8),0.043,1,,
Caffeine Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,8 (8),0.043,1,,
Galactosemia III,SMPDB,1,UGPA_HUMAN,8 (8),0.043,1,,
Galactosemia II (GALK),SMPDB,1,UGPA_HUMAN,8 (8),0.043,1,,
Nucleotide Sugars Metabolism,SMPDB,1,UGPA_HUMAN,8 (8),0.043,1,,
Synaptic vesicle cycle - Homo sapiens (human),KEGG,2,VPP3_HUMAN;CPLX4_HUMAN,63 (63),0.0467,1,,
Synthesis of substrates in N-glycan biosythesis,Reactome,2,SIA7E_HUMAN;SIA10_HUMAN,63 (63),0.0467,1,,
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Reactome,1,CP1A2_HUMAN,9 (9),0.0483,1,,
Displacement of DNA glycosylase by APEX1,Reactome,1,SMUG1_HUMAN,9 (9),0.0483,1,,
Pravastatin Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,9 (9),0.0483,1,,
Codeine and Morphine Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,9 (9),0.0483,1,,
Clopidogrel Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,9 (9),0.0483,1,,
Erlotinib Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,9 (9),0.0483,1,,
Clopidogrel Metabolism Pathway,SMPDB,1,CP1A2_HUMAN,9 (9),0.0483,1,,
Clopidogrel Action Pathway,SMPDB,1,CP1A2_HUMAN,9 (9),0.0483,1,,
rRNA processing,Reactome,2,WDR43_HUMAN;DHX37_HUMAN,65 (65),0.0494,1,,
Digestion of dietary carbohydrate,Reactome,1,CHIT1_HUMAN,10 (10),0.0535,1,,
Uptake and function of anthrax toxins,Reactome,1,MP2K3_HUMAN,10 (10),0.0535,1,,
Biosynthesis of maresins,Reactome,1,CP1A2_HUMAN,10 (10),0.0535,1,,
alternative complement pathway,BioCarta,1,CO8A_HUMAN,10 (10),0.0535,1,,
Base-Excision Repair_ AP Site Formation,Reactome,1,SMUG1_HUMAN,10 (10),0.0535,1,,
Vinka Alkaloid Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,10 (10),0.0535,1,,
Fluoropyrimidine Pathway_ Pharmacodynamics,PharmGKB,1,SMUG1_HUMAN,10 (10),0.0535,1,,
Vincristine Action Pathway,SMPDB,1,MRP2_HUMAN,10 (10),0.0535,1,,
Vindesine Action Pathway,SMPDB,1,MRP2_HUMAN,10 (10),0.0535,1,,
Signaling events mediated by VEGFR1 and VEGFR2,PID,2,MP2K3_HUMAN;SH22A_HUMAN,68 (68),0.0535,1,,
TP53 Regulates Transcription of DNA Repair Genes,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,69 (70),0.0549,1,,
Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,2,MBTP1_HUMAN;VLDLR_HUMAN,69 (69),0.0549,1,,
Metabolism of carbohydrates,Reactome,4,UGPA_HUMAN;MRP5_HUMAN;SIA10_HUMAN;HS3S6_HUMAN,263 (264),0.0561,1,,
miR-targeted genes in epithelium - TarBase,Wikipathways,4,SYNE1_HUMAN;VPS39_HUMAN;PICAL_HUMAN;CTDS1_HUMAN,267 (333),0.0587,1,,
Imatinib Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,CP1A2_HUMAN,11 (11),0.0587,1,,
Benzodiazepine Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,11 (11),0.0587,1,,
Vinblastine Action Pathway,SMPDB,1,MRP2_HUMAN,11 (11),0.0587,1,,
Vinorelbine Action Pathway,SMPDB,1,MRP2_HUMAN,11 (11),0.0587,1,,
GLUT-1 deficiency syndrome,SMPDB,1,UGPA_HUMAN,11 (11),0.0587,1,,
Congenital disorder of glycosylation CDG-IId,SMPDB,1,UGPA_HUMAN,11 (11),0.0587,1,,
Lactose Synthesis,SMPDB,1,UGPA_HUMAN,11 (11),0.0587,1,,
Glycogen synthesis,Reactome,1,UGPA_HUMAN,11 (11),0.0587,1,,
Hyaluronan metabolism,Reactome,1,MRP5_HUMAN,12 (12),0.0639,1,,
Signaling mediated by p38-gamma and p38-delta,PID,1,MP2K3_HUMAN,12 (12),0.0639,1,,
VLDLR internalisation and degradation,Reactome,1,VLDLR_HUMAN,12 (12),0.0639,1,,
lectin induced complement pathway,BioCarta,1,CO8A_HUMAN,12 (12),0.0639,1,,
Pre-NOTCH Processing in Golgi,Reactome,1,SIA10_HUMAN,12 (12),0.0639,1,,
melatonin degradation I,HumanCyc,1,CP1A2_HUMAN,12 (12),0.0639,1,,
Transcription of the HIV genome,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,76 (77),0.0651,1,,
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,2,SIA7E_HUMAN;SIA10_HUMAN,78 (78),0.0682,1,,
the 41bb-dependent immune response,BioCarta,1,MP2K3_HUMAN,13 (13),0.069,1,,
Galactose metabolism,INOH,1,UGPA_HUMAN,13 (13),0.069,1,,
Irinotecan Pathway,Wikipathways,1,MRP2_HUMAN,13 (13),0.069,1,,
superpathway of melatonin degradation,HumanCyc,1,CP1A2_HUMAN,13 (13),0.069,1,,
Platinum Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,MRP2_HUMAN,13 (13),0.069,1,,
Taxane Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,13 (13),0.069,1,,
Methotrexate Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,13 (13),0.069,1,,
Mycophenolic acid Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,MRP2_HUMAN,13 (13),0.069,1,,
Irinotecan Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,13 (13),0.069,1,,
Galactose Metabolism,SMPDB,1,UGPA_HUMAN,13 (13),0.069,1,,
Galactosemia,SMPDB,1,UGPA_HUMAN,13 (13),0.069,1,,
Estrogen Receptor Pathway,Wikipathways,1,CP1A2_HUMAN,13 (13),0.069,1,,
TP53 Regulates Transcription of Cell Cycle Genes,Wikipathways,1,PLK2_HUMAN,13 (13),0.069,1,,
Complement and coagulation cascades - Homo sapiens (human),KEGG,2,FA12_HUMAN;CO8A_HUMAN,79 (79),0.0697,1,,
Asparagine N-linked glycosylation,Reactome,4,NGLY1_HUMAN;SIA7E_HUMAN;SIA10_HUMAN;LMA1L_HUMAN,286 (286),0.0717,1,,
miR-targeted genes in lymphocytes - TarBase,Wikipathways,5,VPS39_HUMAN;PDE3A_HUMAN;PICAL_HUMAN;UFO_HUMAN;SYNE1_HUMAN,409 (489),0.0734,1,,
Methylation,Reactome,1,CP1A2_HUMAN,14 (15),0.0741,1,,
Assembly of active LPL and LIPC lipase complexes,Reactome,1,MBTP1_HUMAN,14 (14),0.0741,1,,
classical complement pathway,BioCarta,1,CO8A_HUMAN,14 (14),0.0741,1,,
Atorvastatin/Lovastatin/Simvastatin Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,14 (14),0.0741,1,,
Irinotecan Pathway_ Pharmacodynamics,PharmGKB,1,MRP2_HUMAN,14 (14),0.0741,1,,
Global Genome Nucleotide Excision Repair (GG-NER),Reactome,2,CSN6_HUMAN;ARP8_HUMAN,84 (84),0.0775,1,,
triacylglycerol degradation,HumanCyc,1,LIPS_HUMAN,15 (15),0.0792,1,,
BMP2 signaling TAK1,INOH,1,MP2K3_HUMAN,15 (15),0.0792,1,,
Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human),KEGG,1,SIA7E_HUMAN,15 (15),0.0792,1,,
Estrogen Metabolism Pathway,PharmGKB,1,CP1A2_HUMAN,15 (15),0.0792,1,,
Mercaptopurine Metabolism Pathway,SMPDB,1,MRP5_HUMAN,15 (15),0.0792,1,,
Fatty Acid Omega Oxidation,Wikipathways,1,CP1A2_HUMAN,15 (15),0.0792,1,,
Transcriptional misregulation in cancer - Homo sapiens (human),KEGG,3,CCNT2_HUMAN;AF9_HUMAN;JHD2C_HUMAN,185 (186),0.0811,1,,
human cytomegalovirus and map kinase pathways,BioCarta,1,MP2K3_HUMAN,16 (16),0.0843,1,,
Ibuprofen Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,16 (16),0.0843,1,,
Mycophenolic Acid Metabolism Pathway,SMPDB,1,MRP2_HUMAN,16 (16),0.0843,1,,
Glycosphingolipid biosynthesis - neolactoseries,EHMN,1,SIA10_HUMAN,16 (16),0.0843,1,,
Codeine and Morphine Metabolism,Wikipathways,1,MRP2_HUMAN,16 (16),0.0843,1,,
miR-targeted genes in adipocytes - TarBase,Wikipathways,1,PICAL_HUMAN,16 (34),0.0843,1,,
Selenocompound metabolism - Homo sapiens (human),KEGG,1,SPS1_HUMAN,17 (17),0.0893,1,,
endocytotic role of ndk phosphins and dynamin,BioCarta,1,PICAL_HUMAN,17 (17),0.0893,1,,
Drug Induction of Bile Acid Pathway,Wikipathways,1,MRP2_HUMAN,17 (17),0.0893,1,,
Mycophenolic acid Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,17 (17),0.0893,1,,
Doxorubicin Metabolism Pathway,SMPDB,1,MRP2_HUMAN,17 (17),0.0893,1,,
Sialuria or French Type Sialuria,SMPDB,1,CHIT1_HUMAN,17 (17),0.0893,1,,
Sialuria or French Type Sialuria,SMPDB,1,CHIT1_HUMAN,17 (17),0.0893,1,,
Amino Sugar Metabolism,SMPDB,1,CHIT1_HUMAN,17 (17),0.0893,1,,
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease,SMPDB,1,CHIT1_HUMAN,17 (17),0.0893,1,,
Tay-Sachs Disease,SMPDB,1,CHIT1_HUMAN,17 (17),0.0893,1,,
Salla Disease/Infantile Sialic Acid Storage Disease,SMPDB,1,CHIT1_HUMAN,17 (17),0.0893,1,,
4-hydroxytamoxifen_ Dexamethasone_ and Retinoic Acids Regulation of p27 Expression,Wikipathways,1,MP2K3_HUMAN,17 (17),0.0893,1,,
VEGFA-VEGFR2 Pathway,Reactome,2,UFO_HUMAN;SH22A_HUMAN,92 (92),0.0906,1,,
Nuclear Receptors Meta-Pathway,Wikipathways,4,CP1A2_HUMAN;MRP5_HUMAN;MRP2_HUMAN;PLK2_HUMAN,315 (316),0.0943,1,,
Estrogen metabolism,Wikipathways,1,CP1A2_HUMAN,18 (18),0.0943,1,,
Tamoxifen Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,18 (18),0.0943,1,,
Doxorubicin Pathway (Cancer Cell)_ Pharmacodynamics,PharmGKB,1,MRP2_HUMAN,18 (18),0.0943,1,,
Lamivudine Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,MRP2_HUMAN,18 (18),0.0943,1,,
Glycogen synthetase deficiency,SMPDB,1,UGPA_HUMAN,18 (18),0.0943,1,,
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis,SMPDB,1,UGPA_HUMAN,18 (18),0.0943,1,,
Mucopolysaccharidosis VI. Sly syndrome,SMPDB,1,UGPA_HUMAN,18 (18),0.0943,1,,
Sucrase-isomaltase deficiency,SMPDB,1,UGPA_HUMAN,18 (18),0.0943,1,,
Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease,SMPDB,1,UGPA_HUMAN,18 (18),0.0943,1,,
Glycogenosis_ Type VI. Hers disease,SMPDB,1,UGPA_HUMAN,18 (18),0.0943,1,,
Starch and Sucrose Metabolism,SMPDB,1,UGPA_HUMAN,18 (18),0.0943,1,,
Signaling by cytosolic FGFR1 fusion mutants,Reactome,1,LRRF1_HUMAN,18 (18),0.0943,1,,
Lamivudine Metabolism Pathway,SMPDB,1,MRP2_HUMAN,18 (18),0.0943,1,,
cGMP effects,Reactome,1,PDE3A_HUMAN,18 (18),0.0943,1,,
DNA Repair,Reactome,4,SMUG1_HUMAN;CSN6_HUMAN;ARP8_HUMAN;BAZ1B_HUMAN,318 (320),0.0968,1,,
Biosynthesis of DHA-derived SPMs,Reactome,1,CP1A2_HUMAN,19 (19),0.0993,1,,
gata3 participate in activating the th2 cytokine genes expression,BioCarta,1,MP2K3_HUMAN,19 (19),0.0993,1,,
Overview of nanoparticle effects,Wikipathways,1,ITAD_HUMAN,19 (19),0.0993,1,,
Cargo recognition for clathrin-mediated endocytosis,Reactome,2,CSN6_HUMAN;PICAL_HUMAN,99 (99),0.102,1,,
TGF-beta signaling TAK1,INOH,1,MP2K3_HUMAN,20 (20),0.104,1,,
Regulation of cytoplasmic and nuclear SMAD2/3 signaling,PID,1,CTDS1_HUMAN,20 (20),0.104,1,,
lissencephaly gene (lis1) in neuronal migration and development,BioCarta,1,DYH1_HUMAN,20 (20),0.104,1,,
Statin Pathway - Generalized_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,20 (20),0.104,1,,
Phenytoin Pathway_ Pharmacokinetics,PharmGKB,1,CP1A2_HUMAN,20 (20),0.104,1,,
Zidovudine Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,MRP5_HUMAN,20 (20),0.104,1,,
Aminocaproic Acid Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Tranexamic Acid Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Urokinase Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Reteplase Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Streptokinase Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Tenecteplase Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Alteplase Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Anistreplase Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Aprotinin Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Phenindione Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Dicoumarol Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Warfarin Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Acenocoumarol Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Coagulation ,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Bivalirudin Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Argatroban Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Phenprocoumon Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Dicumarol Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Ximelagatran Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Lepirudin Action Pathway,SMPDB,1,FA12_HUMAN,20 (20),0.104,1,,
Globo Sphingolipid Metabolism,Wikipathways,1,SIA7E_HUMAN,20 (20),0.104,1,,
Signaling by VEGF,Reactome,2,UFO_HUMAN;SH22A_HUMAN,100 (100),0.104,1,,
Integrin-mediated Cell Adhesion,Wikipathways,2,ITAD_HUMAN;MP2K3_HUMAN,100 (101),0.104,1,,
Tamoxifen metabolism,Wikipathways,1,CP1A2_HUMAN,21 (21),0.109,1,,
Unfolded Protein Response (UPR),Reactome,1,MBTP1_HUMAN,21 (21),0.109,1,,
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,1,CP1A2_HUMAN,21 (21),0.109,1,,
activated TAK1 mediates p38 MAPK activation,Reactome,1,MP2K3_HUMAN,21 (21),0.109,1,,
Aflatoxin activation and detoxification,Reactome,1,CP1A2_HUMAN,21 (22),0.109,1,,
Ardeparin Action Pathway,SMPDB,1,FA12_HUMAN,21 (21),0.109,1,,
Heparin Action Pathway,SMPDB,1,FA12_HUMAN,21 (21),0.109,1,,
Fondaparinux Action Pathway,SMPDB,1,FA12_HUMAN,21 (21),0.109,1,,
Enoxaparin Action Pathway,SMPDB,1,FA12_HUMAN,21 (21),0.109,1,,
Vitamin D in inflammatory diseases,Wikipathways,1,MP2K3_HUMAN,22 (22),0.114,1,,
Complement Activation,Wikipathways,1,CO8A_HUMAN,22 (22),0.114,1,,
Cellular roles of Anthrax toxin,PID,1,MP2K3_HUMAN,22 (22),0.114,1,,
Intrinsic Pathway of Fibrin Clot Formation,Reactome,1,FA12_HUMAN,22 (22),0.114,1,,
heparan sulfate biosynthesis (late stages),HumanCyc,1,HS3S6_HUMAN,22 (22),0.114,1,,
Doxorubicin Pathway_ Pharmacokinetics,PharmGKB,1,MRP2_HUMAN,22 (22),0.114,1,,
Digestion,Reactome,1,CHIT1_HUMAN,22 (22),0.114,1,,
Dengue-2 Interactions with Blood Clotting Cascade,Wikipathways,1,FA12_HUMAN,22 (22),0.114,1,,
Glycogen metabolism,Reactome,1,UGPA_HUMAN,22 (22),0.114,1,,
Thermogenesis,Wikipathways,2,MP2K3_HUMAN;LIPS_HUMAN,108 (108),0.118,1,,
TLR ECSIT MEKK1 p38,INOH,1,MP2K3_HUMAN,23 (23),0.119,1,,
caspase cascade in apoptosis,BioCarta,1,GDIR2_HUMAN,23 (23),0.119,1,,
tnf/stress related signaling,BioCarta,1,MP2K3_HUMAN,23 (23),0.119,1,,
intrinsic prothrombin activation pathway,BioCarta,1,FA12_HUMAN,23 (23),0.119,1,,
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Reactome,1,PLK2_HUMAN,23 (23),0.119,1,,
Irinotecan Action Pathway,SMPDB,1,MRP2_HUMAN,23 (23),0.119,1,,
Irinotecan Metabolism Pathway,SMPDB,1,MRP2_HUMAN,23 (23),0.119,1,,
Blood Clotting Cascade,Wikipathways,1,FA12_HUMAN,23 (23),0.119,1,,
BBSome-mediated cargo-targeting to cilium,Reactome,1,BBS1_HUMAN,23 (23),0.119,1,,
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Wikipathways,1,MRP2_HUMAN,23 (23),0.119,1,,
Purine metabolism,EHMN,3,AT2C1_HUMAN;VPP3_HUMAN;MRP5_HUMAN,223 (223),0.123,1,,
Triglyceride catabolism,Reactome,1,LIPS_HUMAN,24 (24),0.124,1,,
Fluoropyrimidine Pathway_ Pharmacokinetics,PharmGKB,1,MRP5_HUMAN,24 (24),0.124,1,,
Physiological and Pathological Hypertrophy of the Heart,Wikipathways,1,MP2K3_HUMAN,24 (24),0.124,1,,
Triacylglyceride Synthesis,Wikipathways,1,LIPS_HUMAN,24 (24),0.124,1,,
Nucleotide Excision Repair,Reactome,2,CSN6_HUMAN;ARP8_HUMAN,112 (113),0.126,1,,
Phase II - Conjugation of compounds,Reactome,2,UGPA_HUMAN;CP1A2_HUMAN,113 (115),0.127,1,,
Glucuronidation,Reactome,1,UGPA_HUMAN,25 (25),0.129,1,,
Uptake and actions of bacterial toxins,Reactome,1,MP2K3_HUMAN,25 (25),0.129,1,,
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Reactome,1,CCNT2_HUMAN,25 (25),0.129,1,,
Nitric oxide stimulates guanylate cyclase,Reactome,1,PDE3A_HUMAN,25 (25),0.129,1,,
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease,Wikipathways,1,LTBP2_HUMAN,25 (25),0.129,1,,
Thermogenesis - Homo sapiens (human),KEGG,3,NDUAA_HUMAN;MP2K3_HUMAN;LIPS_HUMAN,229 (229),0.131,1,,
Glucuronidation,Wikipathways,1,UGPA_HUMAN,26 (26),0.133,1,,
Other interleukin signaling,Reactome,1,IL16_HUMAN,26 (26),0.133,1,,
TLR ECSIT MEKK1 JNK,INOH,1,MP2K3_HUMAN,26 (26),0.133,1,,
Fertilization,Reactome,1,IZUM1_HUMAN,26 (26),0.133,1,,
Insulin receptor recycling,Reactome,1,VPP3_HUMAN,26 (26),0.133,1,,
TSH,NetPath,1,MP2K3_HUMAN,26 (26),0.133,1,,
Xenobiotics,Reactome,1,CP1A2_HUMAN,26 (26),0.133,1,,
links between pyk2 and map kinases,BioCarta,1,MP2K3_HUMAN,26 (26),0.133,1,,
Vitamin A (retinol) metabolism,EHMN,1,CP1A2_HUMAN,26 (26),0.133,1,,
Termination of O-glycan biosynthesis,Reactome,1,MUC5A_HUMAN,26 (26),0.133,1,,
Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human),KEGG,1,SIA10_HUMAN,27 (27),0.138,1,,
Collecting duct acid secretion - Homo sapiens (human),KEGG,1,VPP3_HUMAN,27 (27),0.138,1,,
Digestion and absorption,Reactome,1,CHIT1_HUMAN,27 (27),0.138,1,,
Keratan sulfate biosynthesis,Reactome,1,SIA10_HUMAN,28 (28),0.143,1,,
Reelin signaling pathway,PID,1,VLDLR_HUMAN,28 (28),0.143,1,,
adp-ribosylation factor,BioCarta,1,RHG06_HUMAN,28 (28),0.143,1,,
Dectin-2 family,Reactome,1,MUC5A_HUMAN,29 (29),0.148,1,,
Linoleic acid metabolism - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,29 (29),0.148,1,,
p38 MAPK signaling pathway,PID,1,MP2K3_HUMAN,29 (29),0.148,1,,
heparan sulfate biosynthesis,HumanCyc,1,HS3S6_HUMAN,29 (29),0.148,1,,
Lipid Metabolism Pathway,Wikipathways,1,LIPS_HUMAN,29 (29),0.148,1,,
MAPK Cascade,Wikipathways,1,MP2K3_HUMAN,29 (29),0.148,1,,
Plasma lipoprotein remodeling,Reactome,1,MBTP1_HUMAN,30 (30),0.152,1,,
Beta2 integrin cell surface interactions,PID,1,ITAD_HUMAN,30 (30),0.152,1,,
fmlp induced chemokine gene expression in hmc-1 cells,BioCarta,1,MP2K3_HUMAN,30 (30),0.152,1,,
Molecules associated with elastic fibres,Reactome,1,LTBP2_HUMAN,30 (31),0.152,1,,
Acyl chain remodelling of PE,Reactome,1,HRSL2_HUMAN,30 (30),0.152,1,,
Transport of small molecules,Reactome,6,VPP3_HUMAN;MRP5_HUMAN;VLDLR_HUMAN;MBTP1_HUMAN;AT2C1_HUMAN;MRP2_HUMAN,665 (666),0.156,1,,
Transferrin endocytosis and recycling,Reactome,1,VPP3_HUMAN,31 (31),0.157,1,,
Mucin type O-glycan biosynthesis - Homo sapiens (human),KEGG,1,GLTL6_HUMAN,31 (31),0.157,1,,
HS-GAG biosynthesis,Reactome,1,HS3S6_HUMAN,31 (31),0.157,1,,
Regulation of p38-alpha and p38-beta,PID,1,MP2K3_HUMAN,31 (31),0.157,1,,
Lissencephaly gene (LIS1) in neuronal migration and development,PID,1,VLDLR_HUMAN,31 (31),0.157,1,,
Regulation of cholesterol biosynthesis by SREBP (SREBF),Reactome,1,MBTP1_HUMAN,31 (31),0.157,1,,
Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,1,CP1A2_HUMAN,31 (31),0.157,1,,
FGFR1 mutant receptor activation,Reactome,1,LRRF1_HUMAN,31 (31),0.157,1,,
Infectious disease,Reactome,3,CCNT2_HUMAN;SSRP1_HUMAN;MP2K3_HUMAN,251 (253),0.159,1,,
Ebola Virus Pathway on Host,Wikipathways,2,VPS39_HUMAN;UFO_HUMAN,130 (130),0.159,1,,
ROS_ RNS production in phagocytes,Reactome,1,VPP3_HUMAN,32 (32),0.162,1,,
rho cell motility signaling pathway,BioCarta,1,RHG06_HUMAN,32 (34),0.162,1,,
Constitutive Androstane Receptor Pathway,Wikipathways,1,MRP2_HUMAN,32 (32),0.162,1,,
Thiopurine Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,MRP5_HUMAN,32 (32),0.162,1,,
Oxidative phosphorylation - Homo sapiens (human),KEGG,2,VPP3_HUMAN;NDUAA_HUMAN,133 (133),0.165,1,,
Serotonin HTR1 Group and FOS Pathway,Wikipathways,1,MP2K3_HUMAN,33 (33),0.166,1,,
Keratan sulfate/keratin metabolism,Reactome,1,SIA10_HUMAN,33 (33),0.166,1,,
Trk receptor signaling mediated by the MAPK pathway,PID,1,MP2K3_HUMAN,33 (33),0.166,1,,
Plasma lipoprotein clearance,Reactome,1,VLDLR_HUMAN,33 (33),0.166,1,,
Base excision repair - Homo sapiens (human),KEGG,1,SMUG1_HUMAN,33 (33),0.166,1,,
Cargo concentration in the ER,Reactome,1,LMA1L_HUMAN,33 (33),0.166,1,,
Imipramine Action Pathway,SMPDB,1,CP1A2_HUMAN,33 (33),0.166,1,,
Pregnane X Receptor pathway,Wikipathways,1,MRP2_HUMAN,33 (33),0.166,1,,
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Reactome,1,NGLY1_HUMAN,34 (34),0.171,1,,
Pentose and glucuronate interconversions - Homo sapiens (human),KEGG,1,UGPA_HUMAN,34 (34),0.171,1,,
Fatty Acid Beta Oxidation,Wikipathways,1,LIPS_HUMAN,34 (34),0.171,1,,
Melatonin metabolism and effects,Wikipathways,1,CP1A2_HUMAN,34 (34),0.171,1,,
Clathrin-mediated endocytosis,Reactome,2,CSN6_HUMAN;PICAL_HUMAN,138 (138),0.175,1,,
Elastic fibre formation,Reactome,1,LTBP2_HUMAN,35 (36),0.175,1,,
Prion diseases - Homo sapiens (human),KEGG,1,CO8A_HUMAN,35 (35),0.175,1,,
toll-like receptor pathway,BioCarta,1,MP2K3_HUMAN,35 (35),0.175,1,,
Striated Muscle Contraction,Reactome,1,TITIN_HUMAN,35 (35),0.175,1,,
Glycogen Synthesis and Degradation,Wikipathways,1,UGPA_HUMAN,36 (36),0.18,1,,
rac1 cell motility signaling pathway,BioCarta,1,RHG06_HUMAN,36 (38),0.18,1,,
Late Phase of HIV Life Cycle,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,141 (143),0.181,1,,
NRF2 pathway,Wikipathways,2,MRP5_HUMAN;MRP2_HUMAN,142 (142),0.183,1,,
Tat-mediated HIV elongation arrest and recovery,Reactome,1,SSRP1_HUMAN,37 (38),0.184,1,,
Pausing and recovery of Tat-mediated HIV elongation,Reactome,1,SSRP1_HUMAN,37 (38),0.184,1,,
MAPK6/MAPK4 signaling,Reactome,1,BORG3_HUMAN,37 (39),0.184,1,,
signal transduction through il1r,BioCarta,1,MP2K3_HUMAN,37 (37),0.184,1,,
Resolution of Abasic Sites (AP sites),Reactome,1,SMUG1_HUMAN,37 (37),0.184,1,,
Base Excision Repair,Reactome,1,SMUG1_HUMAN,37 (37),0.184,1,,
G13 Signaling Pathway,Wikipathways,1,GDIR2_HUMAN,38 (38),0.189,1,,
CXCR3-mediated signaling events,PID,1,MP2K3_HUMAN,38 (38),0.189,1,,
Apoptotic cleavage of cellular proteins,Reactome,1,BAP31_HUMAN,38 (38),0.189,1,,
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Reactome,1,CCNT2_HUMAN,38 (38),0.189,1,,
Triglyceride metabolism,Reactome,1,LIPS_HUMAN,38 (38),0.189,1,,
Signaling by FGFR1 in disease,Reactome,1,LRRF1_HUMAN,38 (38),0.189,1,,
Striated Muscle Contraction Pathway,Wikipathways,1,TITIN_HUMAN,38 (38),0.189,1,,
Formation of Fibrin Clot (Clotting Cascade),Reactome,1,FA12_HUMAN,39 (39),0.193,1,,
Tryptophan metabolism - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,40 (40),0.198,1,,
Pre-NOTCH Expression and Processing,Reactome,1,SIA10_HUMAN,40 (42),0.198,1,,
BMP receptor signaling,PID,1,CTDS1_HUMAN,41 (41),0.202,1,,
Nucleotide-binding Oligomerization Domain (NOD) pathway,Wikipathways,1,CSN6_HUMAN,41 (41),0.202,1,,
actions of nitric oxide in the heart,BioCarta,1,PDE3A_HUMAN,42 (42),0.206,1,,
Fc Epsilon Receptor I Signaling in Mast Cells,SMPDB,1,MP2K3_HUMAN,42 (42),0.206,1,,
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation,Wikipathways,1,GDIR2_HUMAN,42 (43),0.206,1,,
HIV Life Cycle,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,154 (156),0.207,1,,
Signaling by Rho GTPases,Reactome,4,ARHGJ_HUMAN;MYO9B_HUMAN;RHG06_HUMAN;GDIR2_HUMAN,431 (435),0.211,1,,
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,PID,1,VLDLR_HUMAN,44 (44),0.215,1,,
Vasopressin-regulated water reabsorption - Homo sapiens (human),KEGG,1,GDIR2_HUMAN,44 (44),0.215,1,,
Carbohydrate digestion and absorption - Homo sapiens (human),KEGG,1,MGAL_HUMAN,44 (44),0.215,1,,
Tacrolimus/Cyclosporine Pathway_ Pharmacodynamics,PharmGKB,1,MP2K3_HUMAN,44 (44),0.215,1,,
Structural Pathway of Interleukin 1 (IL-1),Wikipathways,1,MP2K3_HUMAN,44 (44),0.215,1,,
Epithelial to mesenchymal transition in colorectal cancer,Wikipathways,2,CTDS1_HUMAN;MP2K3_HUMAN,159 (160),0.217,1,,
Post-translational protein modification,Reactome,10,SIA10_HUMAN;CSN6_HUMAN;GLTL6_HUMAN;MUC5A_HUMAN;GCNT7_HUMAN;MBTP1_HUMAN;ARP8_HUMAN;SIA7E_HUMAN;NGLY1_HUMAN;LMA1L_HUMAN,1377 (1383),0.219,1,,
Insulin Signaling,Wikipathways,2,MP2K3_HUMAN;LIPS_HUMAN,160 (160),0.219,1,,
superpathway of tryptophan utilization,HumanCyc,1,CP1A2_HUMAN,45 (45),0.22,1,,
RhoA signaling pathway,PID,1,MP2K3_HUMAN,45 (45),0.22,1,,
TGF-Ncore,Signalink,1,CTDS1_HUMAN,45 (45),0.22,1,,
Glycolysis Gluconeogenesis,INOH,1,UGPA_HUMAN,45 (46),0.22,1,,
Tryptophan metabolism,Wikipathways,1,CP1A2_HUMAN,46 (46),0.224,1,,
TNF receptor signaling pathway ,PID,1,MP2K3_HUMAN,46 (46),0.224,1,,
Proton Pump Inhibitor Pathway_ Pharmacodynamics,PharmGKB,1,PDE3A_HUMAN,46 (46),0.224,1,,
Regulation of Microtubule Cytoskeleton,Wikipathways,1,TESK2_HUMAN,46 (46),0.224,1,,
Aryl Hydrocarbon Receptor,Wikipathways,1,CP1A2_HUMAN,46 (46),0.224,1,,
Aryl Hydrocarbon Receptor Pathway,Wikipathways,1,CP1A2_HUMAN,46 (46),0.224,1,,
Validated transcriptional targets of deltaNp63 isoforms,PID,1,UFO_HUMAN,47 (48),0.228,1,,
Signaling by FGFR in disease,Reactome,1,LRRF1_HUMAN,47 (47),0.228,1,,
Mercaptopurine Action Pathway,SMPDB,1,MRP5_HUMAN,47 (47),0.228,1,,
Azathioprine Action Pathway,SMPDB,1,MRP5_HUMAN,47 (47),0.228,1,,
Thioguanine Action Pathway,SMPDB,1,MRP5_HUMAN,47 (47),0.228,1,,
NO-cGMP-PKG mediated Neuroprotection,Wikipathways,1,PDE3A_HUMAN,47 (47),0.228,1,,
Exercise-induced Circadian Regulation,Wikipathways,1,UGPA_HUMAN,48 (48),0.232,1,,
Formation of HIV-1 elongation complex containing HIV-1 Tat,Reactome,1,SSRP1_HUMAN,49 (50),0.237,1,,
Tat-mediated elongation of the HIV-1 transcript,Reactome,1,SSRP1_HUMAN,49 (50),0.237,1,,
HIV Transcription Elongation,Reactome,1,SSRP1_HUMAN,49 (50),0.237,1,,
Vibrio cholerae infection - Homo sapiens (human),KEGG,1,VPP3_HUMAN,50 (50),0.241,1,,
Photodynamic therapy-induced AP-1 survival signaling.,Wikipathways,1,MP2K3_HUMAN,50 (50),0.241,1,,
Cytosolic sensors of pathogen-associated DNA ,Reactome,1,LRRF1_HUMAN,51 (51),0.245,1,,
Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,51 (51),0.245,1,,
TP53 Regulates Transcription of Cell Cycle Genes,Reactome,1,PLK2_HUMAN,51 (51),0.245,1,,
Aminosugars metabolism,EHMN,1,CHIT1_HUMAN,51 (51),0.245,1,,
Cargo trafficking to the periciliary membrane,Reactome,1,BBS1_HUMAN,51 (51),0.245,1,,
TGF_beta_Receptor,NetPath,2,VPS39_HUMAN;MP2K3_HUMAN,173 (174),0.245,1,,
Apoptotic execution phase,Reactome,1,BAP31_HUMAN,52 (52),0.249,1,,
Phosphodiesterases in neuronal function,Wikipathways,1,PDE3A_HUMAN,52 (52),0.249,1,,
t cell receptor signaling pathway,BioCarta,1,RHG06_HUMAN,53 (55),0.253,1,,
hiv-1 nef: negative effector of fas and tnf,BioCarta,1,GDIR2_HUMAN,53 (53),0.253,1,,
keratinocyte differentiation,BioCarta,1,MP2K3_HUMAN,53 (53),0.253,1,,
Xenobiotics metabolism,EHMN,1,CP1A2_HUMAN,53 (53),0.253,1,,
Copper homeostasis,Wikipathways,1,STEA4_HUMAN,53 (55),0.253,1,,
Ion channel transport,Reactome,2,AT2C1_HUMAN;VPP3_HUMAN,179 (179),0.257,1,,
Interferon type I signaling pathways,Wikipathways,1,MP2K3_HUMAN,54 (54),0.257,1,,
Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,1,HS3S6_HUMAN,54 (54),0.257,1,,
RAC1 signaling pathway,PID,1,MP2K3_HUMAN,54 (54),0.257,1,,
Validated transcriptional targets of TAp63 isoforms,PID,1,SSRP1_HUMAN,54 (55),0.257,1,,
Regulation of lipolysis in adipocytes - Homo sapiens (human),KEGG,1,LIPS_HUMAN,54 (54),0.257,1,,
IL1,NetPath,1,MP2K3_HUMAN,54 (54),0.257,1,,
Cardiac Hypertrophic Response,Wikipathways,1,MP2K3_HUMAN,54 (54),0.257,1,,
Ion transport by P-type ATPases,Reactome,1,AT2C1_HUMAN,55 (55),0.261,1,,
Complex I biogenesis,Reactome,1,NDUAA_HUMAN,55 (55),0.261,1,,
IL-1 signaling pathway,Wikipathways,1,MP2K3_HUMAN,55 (55),0.261,1,,
Vitamin D Receptor Pathway,Wikipathways,2,STEA4_HUMAN;MYO9B_HUMAN,182 (184),0.263,1,,
Golgi Associated Vesicle Biogenesis,Reactome,1,PICAL_HUMAN,56 (56),0.265,1,,
Formation of TC-NER Pre-Incision Complex,Reactome,1,CSN6_HUMAN,56 (57),0.265,1,,
Metapathway biotransformation Phase I and II,Wikipathways,2,CP1A2_HUMAN;HS3S6_HUMAN,184 (186),0.267,1,,
mapkinase signaling pathway,BioCarta,1,MP2K3_HUMAN,57 (57),0.27,1,,
Iron uptake and transport,Reactome,1,VPP3_HUMAN,58 (58),0.274,1,,
VEGF,INOH,2,MP2K3_HUMAN;SH22A_HUMAN,188 (188),0.276,1,,
Complement and Coagulation Cascades,Wikipathways,1,FA12_HUMAN,59 (59),0.278,1,,
VEGF signaling pathway - Homo sapiens (human),KEGG,1,SH22A_HUMAN,59 (59),0.278,1,,
NRAGE signals death through JNK,Reactome,1,ARHGJ_HUMAN,59 (61),0.278,1,,
C21-steroid hormone biosynthesis and metabolism,EHMN,1,CP1A2_HUMAN,59 (59),0.278,1,,
Oxidative phosphorylation,Wikipathways,1,NDUAA_HUMAN,60 (61),0.282,1,,
Steroid hormone biosynthesis - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,60 (60),0.282,1,,
Dengue-2 Interactions with Complement and Coagulation Cascades,Wikipathways,1,FA12_HUMAN,60 (60),0.282,1,,
TYROBP Causal Network,Wikipathways,1,VPP3_HUMAN,60 (60),0.282,1,,
Arachidonic acid metabolism,Reactome,1,CP1A2_HUMAN,61 (62),0.285,1,,
Coregulation of Androgen receptor activity,PID,1,CTDS1_HUMAN,61 (61),0.285,1,,
VEGF Signaling Pathway,PharmGKB,1,MP2K3_HUMAN,61 (61),0.285,1,,
Huntington disease - Homo sapiens (human),KEGG,2,NDUAA_HUMAN;DYH1_HUMAN,193 (193),0.286,1,,
Oxidation by Cytochrome P450,Wikipathways,1,CP1A2_HUMAN,62 (62),0.289,1,,
TLR JNK,INOH,1,MP2K3_HUMAN,62 (62),0.289,1,,
Leptin,NetPath,1,PDE3A_HUMAN,62 (62),0.289,1,,
IL-1 JNK,INOH,1,MP2K3_HUMAN,62 (62),0.289,1,,
HIV Infection,Reactome,2,CCNT2_HUMAN;SSRP1_HUMAN,195 (197),0.29,1,,
TLR p38,INOH,1,MP2K3_HUMAN,63 (63),0.293,1,,
IL12-mediated signaling events,PID,1,MP2K3_HUMAN,63 (65),0.293,1,,
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,1,CP1A2_HUMAN,63 (63),0.293,1,,
Pathways Affected in Adenoid Cystic Carcinoma,Wikipathways,1,JHD2C_HUMAN,63 (63),0.293,1,,
Metabolism of lipids,Reactome,5,MBTP1_HUMAN;CP1A2_HUMAN;PLPL7_HUMAN;HRSL2_HUMAN;LIPS_HUMAN,660 (664),0.295,1,,
cAMP signaling pathway - Homo sapiens (human),KEGG,2,PDE3A_HUMAN;LIPS_HUMAN,199 (199),0.298,1,,
Interleukin-17 signaling,Reactome,1,MP2K3_HUMAN,65 (65),0.301,1,,
Renin secretion - Homo sapiens (human),KEGG,1,PDE3A_HUMAN,65 (65),0.301,1,,
MAP kinase activation,Reactome,1,MP2K3_HUMAN,65 (65),0.301,1,,
Disease,Reactome,4,LRRF1_HUMAN;CCNT2_HUMAN;SSRP1_HUMAN;MP2K3_HUMAN,508 (510),0.304,1,,
Integrin cell surface interactions,Reactome,1,ITAD_HUMAN,66 (67),0.305,1,,
Signaling by ROBO receptors,Reactome,1,MYO9B_HUMAN,66 (66),0.305,1,,
IL-1 p38,INOH,1,MP2K3_HUMAN,66 (66),0.305,1,,
Human Thyroid Stimulating Hormone (TSH) signaling pathway,Wikipathways,1,MP2K3_HUMAN,66 (66),0.305,1,,
Retinol metabolism - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,67 (67),0.309,1,,
Fc epsilon RI signaling pathway - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,67 (68),0.309,1,,
Signaling by TGF-beta Receptor Complex,Reactome,1,CCNT2_HUMAN,67 (67),0.309,1,,
Rap1 signaling pathway - Homo sapiens (human),KEGG,2,MP2K3_HUMAN;RPGF6_HUMAN,206 (206),0.312,1,,
Cytochrome P450 - arranged by substrate type,Reactome,1,CP1A2_HUMAN,68 (68),0.313,1,,
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,1,VPP3_HUMAN,68 (68),0.313,1,,
AMP-activated Protein Kinase (AMPK) Signaling,Wikipathways,1,LIPS_HUMAN,68 (68),0.313,1,,
Sterol Regulatory Element-Binding Proteins (SREBP) signalling,Wikipathways,1,MBTP1_HUMAN,68 (68),0.313,1,,
Endoderm Differentiation,Wikipathways,1,MP2K3_HUMAN,68 (71),0.313,1,,
Tryptophan degradation,INOH,1,CP1A2_HUMAN,69 (69),0.316,1,,
COPII-mediated vesicle transport,Reactome,1,LMA1L_HUMAN,69 (69),0.316,1,,
RNA polymerase II transcribes snRNA genes,Reactome,1,CCNT2_HUMAN,70 (77),0.32,1,,
Glucocorticoid Receptor Pathway,Wikipathways,1,PLK2_HUMAN,70 (71),0.32,1,,
CDC42 signaling events,PID,1,MP2K3_HUMAN,71 (71),0.324,1,,
Bile secretion - Homo sapiens (human),KEGG,1,MRP2_HUMAN,71 (71),0.324,1,,
trans-Golgi Network Vesicle Budding,Reactome,1,PICAL_HUMAN,72 (72),0.328,1,,
Clathrin derived vesicle budding,Reactome,1,PICAL_HUMAN,72 (72),0.328,1,,
Drug metabolism - cytochrome P450 - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,72 (72),0.328,1,,
Phospholipid metabolism,Reactome,2,HRSL2_HUMAN;PLPL7_HUMAN,215 (216),0.33,1,,
Transcriptional Regulation by TP53,Reactome,3,PLK2_HUMAN;SSRP1_HUMAN;CCNT2_HUMAN,372 (374),0.334,1,,
Linoleate metabolism,EHMN,1,CP1A2_HUMAN,74 (74),0.335,1,,
Signaling by Insulin receptor,Reactome,1,VPP3_HUMAN,75 (75),0.339,1,,
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,76 (76),0.342,1,,
Cell death signalling via NRAGE_ NRIF and NADE,Reactome,1,ARHGJ_HUMAN,76 (78),0.342,1,,
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,Reactome,1,BAZ1B_HUMAN,77 (77),0.346,1,,
DNA Double Strand Break Response,Reactome,1,BAZ1B_HUMAN,78 (78),0.35,1,,
Ribosome biogenesis in eukaryotes - Homo sapiens (human),KEGG,1,WDR43_HUMAN,79 (105),0.353,1,,
Transcription-Coupled Nucleotide Excision Repair (TC-NER),Reactome,1,CSN6_HUMAN,80 (81),0.357,1,,
Biological oxidations,Reactome,2,UGPA_HUMAN;CP1A2_HUMAN,229 (231),0.358,1,,
Chemical carcinogenesis - Homo sapiens (human),KEGG,1,CP1A2_HUMAN,82 (82),0.364,1,,
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,1,CP1A2_HUMAN,82 (82),0.364,1,,
Signaling Pathways in Glioblastoma,Wikipathways,1,MP2K3_HUMAN,82 (83),0.364,1,,
C-type lectin receptors (CLRs),Reactome,1,MUC5A_HUMAN,83 (83),0.367,1,,
Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human),KEGG,1,TITIN_HUMAN,83 (83),0.367,1,,
MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,1,MP2K3_HUMAN,83 (102),0.367,1,,
PI Metabolism,Reactome,1,PLPL7_HUMAN,84 (84),0.371,1,,
VEGFA-VEGFR2 Signaling Pathway,Wikipathways,2,MP2K3_HUMAN;SH22A_HUMAN,236 (236),0.372,1,,
MyD88 cascade initiated on plasma membrane,Reactome,1,MP2K3_HUMAN,87 (87),0.381,1,,
Toll Like Receptor 10 (TLR10) Cascade,Reactome,1,MP2K3_HUMAN,87 (87),0.381,1,,
Toll Like Receptor 5 (TLR5) Cascade,Reactome,1,MP2K3_HUMAN,87 (87),0.381,1,,
G alpha (12/13) signalling events,Reactome,1,ARHGJ_HUMAN,87 (89),0.381,1,,
TCR,NetPath,2,GDIR2_HUMAN;SH22A_HUMAN,241 (245),0.382,1,,
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Reactome,1,MP2K3_HUMAN,88 (88),0.385,1,,
Rheumatoid arthritis - Homo sapiens (human),KEGG,1,VPP3_HUMAN,89 (90),0.388,1,,
Dilated cardiomyopathy (DCM) - Homo sapiens (human),KEGG,1,TITIN_HUMAN,89 (90),0.388,1,,
Androgen and estrogen biosynthesis and metabolism,EHMN,1,CP1A2_HUMAN,89 (89),0.388,1,,
Platelet homeostasis,Reactome,1,PDE3A_HUMAN,89 (89),0.388,1,,
Toll Like Receptor 7/8 (TLR7/8) Cascade,Reactome,1,MP2K3_HUMAN,90 (90),0.391,1,,
MyD88 dependent cascade initiated on endosome,Reactome,1,MP2K3_HUMAN,90 (90),0.391,1,,
Morphine addiction - Homo sapiens (human),KEGG,1,PDE3A_HUMAN,91 (91),0.395,1,,
Allograft Rejection,Wikipathways,1,CO8A_HUMAN,91 (91),0.395,1,,
TNF alpha Signaling Pathway,Wikipathways,1,MP2K3_HUMAN,92 (93),0.398,1,,
Human Complement System,Wikipathways,1,CO8A_HUMAN,92 (92),0.398,1,,
IL-17 signaling pathway - Homo sapiens (human),KEGG,1,MUC5A_HUMAN,93 (93),0.401,1,,
GnRH signaling pathway - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,93 (93),0.401,1,,
Regulation of TP53 Activity through Phosphorylation,Reactome,1,SSRP1_HUMAN,93 (93),0.401,1,,
B-WICH complex positively regulates rRNA expression,Reactome,1,BAZ1B_HUMAN,94 (94),0.405,1,,
Toll Like Receptor 9 (TLR9) Cascade,Reactome,1,MP2K3_HUMAN,94 (94),0.405,1,,
Signaling by Interleukins,Reactome,2,IL16_HUMAN;MP2K3_HUMAN,254 (254),0.407,1,,
Amoebiasis - Homo sapiens (human),KEGG,1,CO8A_HUMAN,95 (96),0.408,1,,
Signaling by Receptor Tyrosine Kinases,Reactome,3,VPP3_HUMAN;UFO_HUMAN;SH22A_HUMAN,423 (423),0.411,1,,
Aldosterone synthesis and secretion - Homo sapiens (human),KEGG,1,LIPS_HUMAN,96 (96),0.411,1,,
p75 NTR receptor-mediated signalling,Reactome,1,ARHGJ_HUMAN,96 (99),0.411,1,,
Signaling by TGF-beta family members,Reactome,1,CCNT2_HUMAN,96 (96),0.411,1,,
Toll Like Receptor 3 (TLR3) Cascade,Reactome,1,MP2K3_HUMAN,97 (97),0.415,1,,
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,1,PLPL7_HUMAN,97 (97),0.415,1,,
MyD88:Mal cascade initiated on plasma membrane,Reactome,1,MP2K3_HUMAN,97 (97),0.415,1,,
Toll Like Receptor TLR1:TLR2 Cascade,Reactome,1,MP2K3_HUMAN,97 (97),0.415,1,,
Toll Like Receptor TLR6:TLR2 Cascade,Reactome,1,MP2K3_HUMAN,97 (97),0.415,1,,
Toll Like Receptor 2 (TLR2) Cascade,Reactome,1,MP2K3_HUMAN,97 (97),0.415,1,,
JAK STAT MolecularVariation 1,INOH,1,IL16_HUMAN,98 (98),0.418,1,,
Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,99 (99),0.421,1,,
Respiratory electron transport,Reactome,1,NDUAA_HUMAN,100 (100),0.424,1,,
TRIF(TICAM1)-mediated TLR4 signaling ,Reactome,1,MP2K3_HUMAN,101 (101),0.427,1,,
MyD88-independent TLR4 cascade ,Reactome,1,MP2K3_HUMAN,101 (101),0.427,1,,
Arachidonic acid metabolism,EHMN,1,CP1A2_HUMAN,101 (101),0.427,1,,
Toll-like Receptor Signaling Pathway,Wikipathways,1,MP2K3_HUMAN,102 (102),0.431,1,,
UCH proteinases,Reactome,1,ARP8_HUMAN,102 (102),0.431,1,,
Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,1,NDUAA_HUMAN,103 (103),0.434,1,,
Reproduction,Reactome,1,IZUM1_HUMAN,104 (104),0.437,1,,
Toll-like receptor signaling pathway - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,104 (104),0.437,1,,
Senescence and Autophagy in Cancer,Wikipathways,1,MP2K3_HUMAN,105 (106),0.44,1,,
EGF-Core,Signalink,1,MP2K3_HUMAN,105 (105),0.44,1,,
Leukotriene metabolism,EHMN,1,CP1A2_HUMAN,105 (105),0.44,1,,
ErbB1 downstream signaling,PID,1,SH22A_HUMAN,106 (107),0.443,1,,
Purine nucleotides nucleosides metabolism,INOH,1,PDE3A_HUMAN,107 (108),0.446,1,,
Post-translational protein phosphorylation,Reactome,1,MBTP1_HUMAN,108 (110),0.449,1,,
Positive epigenetic regulation of rRNA expression,Reactome,1,BAZ1B_HUMAN,109 (109),0.452,1,,
Phase I - Functionalization of compounds,Reactome,1,CP1A2_HUMAN,109 (109),0.452,1,,
TNF signaling pathway - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,110 (110),0.455,1,,
Tyrosine metabolism,EHMN,1,CP1A2_HUMAN,110 (110),0.455,1,,
EGFR1,NetPath,3,ZDHC5_HUMAN;MP2K3_HUMAN;UFO_HUMAN,455 (457),0.457,1,,
Toxoplasmosis - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,113 (113),0.464,1,,
ESC Pluripotency Pathways,Wikipathways,1,MP2K3_HUMAN,116 (116),0.473,1,,
Signaling by NOTCH,Reactome,1,SIA10_HUMAN,117 (120),0.476,1,,
Apoptosis,Reactome,1,BAP31_HUMAN,118 (118),0.479,1,,
Extracellular matrix organization,Reactome,2,ITAD_HUMAN;LTBP2_HUMAN,293 (294),0.48,1,,
Neurotrophin signaling pathway - Homo sapiens (human),KEGG,1,GDIR2_HUMAN,119 (119),0.482,1,,
AMPK signaling pathway - Homo sapiens (human),KEGG,1,LIPS_HUMAN,120 (120),0.485,1,,
Programmed Cell Death,Reactome,1,BAP31_HUMAN,121 (121),0.487,1,,
Oocyte meiosis - Homo sapiens (human),KEGG,1,SLK_HUMAN,123 (125),0.493,1,,
Lysosome - Homo sapiens (human),KEGG,1,VPP3_HUMAN,123 (123),0.493,1,,
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,1,NDUAA_HUMAN,123 (123),0.493,1,,
Hemostasis,Reactome,4,FA12_HUMAN;PDE3A_HUMAN;JHD2C_HUMAN;TITIN_HUMAN,662 (668),0.495,1,,
Regulation of Complement cascade,Reactome,1,CO8A_HUMAN,124 (130),0.496,1,,
Integrin,INOH,1,ITAD_HUMAN,124 (124),0.496,1,,
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,2,ITAD_HUMAN;LIPS_HUMAN,302 (302),0.496,1,,
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,1,MBTP1_HUMAN,125 (127),0.499,1,,
Oxidative Stress Induced Senescence,Reactome,1,MP2K3_HUMAN,126 (126),0.502,1,,
miR-targeted genes in leukocytes - TarBase,Wikipathways,1,VPS39_HUMAN,126 (154),0.502,1,,
Toll Like Receptor 4 (TLR4) Cascade,Reactome,1,MP2K3_HUMAN,127 (127),0.504,1,,
Metabolism of steroids,Reactome,1,MBTP1_HUMAN,127 (127),0.504,1,,
Platelet degranulation ,Reactome,1,TITIN_HUMAN,128 (129),0.507,1,,
JAK STAT pathway and regulation,INOH,2,IL16_HUMAN;MP2K3_HUMAN,310 (310),0.51,1,,
Adipogenesis,Wikipathways,1,LIPS_HUMAN,130 (131),0.512,1,,
Factors involved in megakaryocyte development and platelet production,Reactome,1,JHD2C_HUMAN,131 (131),0.515,1,,
Angiopoietin Like Protein 8 Regulatory Pathway,Wikipathways,1,MP2K3_HUMAN,131 (131),0.515,1,,
Systemic lupus erythematosus - Homo sapiens (human),KEGG,1,CO8A_HUMAN,132 (133),0.518,1,,
FoxO signaling pathway - Homo sapiens (human),KEGG,1,PLK2_HUMAN,132 (132),0.518,1,,
Glycerophospholipid biosynthesis,Reactome,1,HRSL2_HUMAN,132 (133),0.518,1,,
TGF-beta Signaling Pathway,Wikipathways,1,MP2K3_HUMAN,132 (132),0.518,1,,
Response to elevated platelet cytosolic Ca2+,Reactome,1,TITIN_HUMAN,133 (134),0.521,1,,
Complement cascade,Reactome,1,CO8A_HUMAN,135 (141),0.526,1,,
Apelin signaling pathway - Homo sapiens (human),KEGG,1,LIPS_HUMAN,137 (137),0.531,1,,
Insulin signaling pathway - Homo sapiens (human),KEGG,1,LIPS_HUMAN,137 (137),0.531,1,,
ER to Golgi Anterograde Transport,Reactome,1,LMA1L_HUMAN,137 (137),0.531,1,,
Death Receptor Signalling,Reactome,1,ARHGJ_HUMAN,138 (141),0.534,1,,
Regulation of toll-like receptor signaling pathway,Wikipathways,1,MP2K3_HUMAN,139 (143),0.536,1,,
Innate Immune System,Reactome,6,MP2K3_HUMAN;VPP3_HUMAN;MUC5A_HUMAN;LRRF1_HUMAN;CO8A_HUMAN;CHIT1_HUMAN,1067 (1077),0.537,1,,
Parkinson disease - Homo sapiens (human),KEGG,1,NDUAA_HUMAN,142 (142),0.544,1,,
Human papillomavirus infection - Homo sapiens (human),KEGG,2,VPP3_HUMAN;BAP31_HUMAN,339 (339),0.558,1,,
Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,1,NDUAA_HUMAN,148 (148),0.559,1,,
Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human),KEGG,1,NDUAA_HUMAN,149 (149),0.561,1,,
Epigenetic regulation of gene expression,Reactome,1,BAZ1B_HUMAN,151 (151),0.566,1,,
Phagosome - Homo sapiens (human),KEGG,1,VPP3_HUMAN,151 (152),0.566,1,,
Nonalcoholic fatty liver disease,Wikipathways,1,NDUAA_HUMAN,154 (155),0.573,1,,
Toll-Like Receptors Cascades,Reactome,1,MP2K3_HUMAN,154 (154),0.573,1,,
Axon guidance,Reactome,2,MYO9B_HUMAN;VLDLR_HUMAN,356 (358),0.585,1,,
Cellular senescence - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,160 (160),0.587,1,,
Regulation of TP53 Activity,Reactome,1,SSRP1_HUMAN,161 (162),0.59,1,,
EGF-EGFR Signaling Pathway,Wikipathways,1,SH22A_HUMAN,162 (162),0.592,1,,
cGMP-PKG signaling pathway - Homo sapiens (human),KEGG,1,PDE3A_HUMAN,163 (163),0.594,1,,
DNA Double-Strand Break Repair,Reactome,1,BAZ1B_HUMAN,168 (169),0.605,1,,
Transport to the Golgi and subsequent modification,Reactome,1,LMA1L_HUMAN,168 (168),0.605,1,,
Tight junction - Homo sapiens (human),KEGG,1,RPGF6_HUMAN,170 (170),0.61,1,,
Influenza A - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,171 (171),0.612,1,,
Alzheimer disease - Homo sapiens (human),KEGG,1,NDUAA_HUMAN,171 (171),0.612,1,,
The citric acid (TCA) cycle and respiratory electron transport,Reactome,1,NDUAA_HUMAN,173 (173),0.616,1,,
Purine metabolism - Homo sapiens (human),KEGG,1,PDE3A_HUMAN,173 (174),0.616,1,,
Membrane Trafficking,Reactome,3,CSN6_HUMAN;LMA1L_HUMAN;PICAL_HUMAN,582 (582),0.625,1,,
Tuberculosis - Homo sapiens (human),KEGG,1,VPP3_HUMAN,178 (179),0.627,1,,
Gene expression (Transcription),Reactome,7,ZN605_HUMAN;BAZ1B_HUMAN;CCNT2_HUMAN;AF9_HUMAN;ZN840_HUMAN;PLK2_HUMAN;SSRP1_HUMAN,1360 (1373),0.628,1,,
IL-7 signaling,INOH,1,MP2K3_HUMAN,185 (185),0.641,1,,
EPO signaling,INOH,1,MP2K3_HUMAN,186 (186),0.643,1,,
Metabolism,Reactome,10,UGPA_HUMAN;NDUAA_HUMAN;SIA10_HUMAN;HRSL2_HUMAN;HS3S6_HUMAN;CP1A2_HUMAN;MRP5_HUMAN;MBTP1_HUMAN;LIPS_HUMAN;PLPL7_HUMAN,1954 (1972),0.645,1,,
Fatty acid metabolism,Reactome,1,CP1A2_HUMAN,187 (189),0.645,1,,
Cilium Assembly,Reactome,1,BBS1_HUMAN,187 (187),0.645,1,,
Cellular Senescence,Reactome,1,MP2K3_HUMAN,188 (189),0.647,1,,
Muscle contraction,Reactome,1,TITIN_HUMAN,195 (195),0.661,1,,
Focal Adhesion,Wikipathways,1,TESK2_HUMAN,198 (198),0.666,1,,
Vesicle-mediated transport,Reactome,3,CSN6_HUMAN;LMA1L_HUMAN;PICAL_HUMAN,620 (620),0.668,1,,
Metabolism of proteins,Reactome,10,SIA10_HUMAN;CSN6_HUMAN;GLTL6_HUMAN;MUC5A_HUMAN;GCNT7_HUMAN;MBTP1_HUMAN;ARP8_HUMAN;SIA7E_HUMAN;NGLY1_HUMAN;LMA1L_HUMAN,1991 (2008),0.669,1,,
Epstein-Barr virus infection - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,200 (201),0.67,1,,
RNA Polymerase II Transcription,Reactome,6,ZN605_HUMAN;CCNT2_HUMAN;AF9_HUMAN;ZN840_HUMAN;PLK2_HUMAN;SSRP1_HUMAN,1223 (1236),0.673,1,,
Human immunodeficiency virus 1 infection - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,212 (212),0.691,1,,
Regulation of actin cytoskeleton - Homo sapiens (human),KEGG,1,ITAD_HUMAN,213 (213),0.693,1,,
Cytokine Signaling in Immune system,Reactome,2,IL16_HUMAN;MP2K3_HUMAN,458 (458),0.722,1,,
Neddylation,Reactome,1,CSN6_HUMAN,234 (235),0.727,1,,
MAPK family signaling cascades,Reactome,1,BORG3_HUMAN,234 (237),0.727,1,,
Organelle biogenesis and maintenance,Reactome,1,BBS1_HUMAN,237 (240),0.732,1,,
Generic Transcription Pathway,Reactome,5,PLK2_HUMAN;ZN605_HUMAN;SSRP1_HUMAN;ZN840_HUMAN;CCNT2_HUMAN,1101 (1107),0.733,1,,
MAPK Signaling Pathway,Wikipathways,1,MP2K3_HUMAN,246 (246),0.745,1,,
Diseases of signal transduction,Reactome,1,LRRF1_HUMAN,248 (248),0.748,1,,
Neutrophil degranulation,Reactome,2,VPP3_HUMAN;CHIT1_HUMAN,488 (490),0.754,1,,
Platelet activation_ signaling and aggregation,Reactome,1,TITIN_HUMAN,259 (260),0.763,1,,
GPCR signaling-G alpha i,INOH,1,IL16_HUMAN,262 (262),0.767,1,,
GPCR signaling-pertussis toxin,INOH,1,IL16_HUMAN,262 (262),0.767,1,,
GPCR signaling-cholera toxin,INOH,1,IL16_HUMAN,270 (270),0.777,1,,
GPCR signaling-G alpha s Epac and ERK,INOH,1,IL16_HUMAN,272 (272),0.779,1,,
GPCR signaling-G alpha q,INOH,1,IL16_HUMAN,274 (274),0.782,1,,
GPCR signaling-G alpha s PKA and ERK,INOH,1,IL16_HUMAN,285 (285),0.795,1,,
Cytokine-cytokine receptor interaction - Homo sapiens (human),KEGG,1,IL16_HUMAN,294 (294),0.805,1,,
MAPK signaling pathway - Homo sapiens (human),KEGG,1,MP2K3_HUMAN,295 (295),0.806,1,,
Deubiquitination,Reactome,1,ARP8_HUMAN,296 (296),0.807,1,,
Metabolism of RNA,Reactome,2,WDR43_HUMAN;DHX37_HUMAN,577 (586),0.831,1,,
Cellular responses to stress,Reactome,1,MP2K3_HUMAN,343 (345),0.852,1,,
Developmental Biology,Reactome,2,MYO9B_HUMAN;VLDLR_HUMAN,618 (620),0.859,1,,
Signal Transduction,Reactome,11,SIA10_HUMAN;VPP3_HUMAN;CCNT2_HUMAN;MYO9B_HUMAN;RHG06_HUMAN;GDIR2_HUMAN;UFO_HUMAN;ARHGJ_HUMAN;PDE3A_HUMAN;SH22A_HUMAN;BORG3_HUMAN,2634 (2647),0.882,1,,
Immune System,Reactome,7,MP2K3_HUMAN;VPP3_HUMAN;MUC5A_HUMAN;IL16_HUMAN;LRRF1_HUMAN;CO8A_HUMAN;CHIT1_HUMAN,1825 (1840),0.89,1,,
Cellular responses to external stimuli,Reactome,1,MP2K3_HUMAN,412 (414),0.9,1,,
G alpha (s) signalling events,Reactome,1,PDE3A_HUMAN,581 (583),0.962,1,,
GPCR downstream signalling,Reactome,2,ARHGJ_HUMAN;PDE3A_HUMAN,1172 (1176),0.991,1,,
Signaling by GPCR,Reactome,2,ARHGJ_HUMAN;PDE3A_HUMAN,1235 (1240),0.993,1,,